Cargando…
Pulmonary manifestations in VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome: a systematic review
BACKGROUND: VEXAS (vacuoles, E1 enzyme, X-linked, auto-inflammatory, somatic) syndrome is a newly described auto-inflammatory disease. Many cases feature pulmonary infiltrates or respiratory failure. This systematic review aimed to summarize respiratory manifestations in VEXAS syndrome described to...
Autores principales: | Kouranloo, Koushan, Ashley, Athea, Zhao, Sizheng Steven, Dey, Mrinalini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126013/ https://www.ncbi.nlm.nih.gov/pubmed/36617363 http://dx.doi.org/10.1007/s00296-022-05266-2 |
Ejemplares similares
-
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome—clinical presentation of a newly described somatic, autoinflammatory syndrome
por: Alhomida, Faris, et al.
Publicado: (2021) -
Innovations in genomics for undiagnosed diseases: vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome
por: Stubbins, Ryan J., et al.
Publicado: (2022) -
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
por: Goyal, Amrita, et al.
Publicado: (2022) -
A systematic review of the incidence, management and prognosis of new-onset autoimmune connective tissue diseases after COVID-19
por: Kouranloo, Koushan, et al.
Publicado: (2023) -
A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment
por: Tozaki, Nagie, et al.
Publicado: (2022)